BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt-associated ascites in pediatric low-grade gliomas.
Saved in:
| Title: | BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt-associated ascites in pediatric low-grade gliomas. |
|---|---|
| Authors: | Amayiri N; Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan., Obeidat M; Department of Surgery, King Hussein Cancer Center, Amman, Jordan., Laban DA; Department of Diagnostic radiology, King Hussein Cancer Center, Amman, Jordan., Musharbash A; Department of Surgery, King Hussein Cancer Center, Amman, Jordan., Al-Hussaini M; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan., Maraqa B; Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman, Jordan., Ibrahimi A; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Sarhan N; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Bouffet E; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31058. Date of Electronic Publication: 2024 May 16. |
| Publication Type: | Letter; Case Reports |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
